Can China Convince World With Its Fast, Cheap COVID Vaccines?

Candidates Gain Traction Outside West

 
• By Brian Yang

As China gears up to the possible launch of its first vaccines against the coronavirus, supported by clearer regulations, many see the candidates as promising and cost-effective, although they may need more convincing data to be widely adopted. Relatively low projected per dose costs are generating interest in trials in multiple countries.

COVID-19 Vaccine. Corona Virus SARS-CoV-2, 2019 nCoV virus destruction. A vaccine against coronavirus disease 2019. Breakthrough in the Creating of a COVID-19 Vaccine.
CHINA MOVES FAST ON COVID-19 VACCINES BUT MORE DATA NEEDED FOR USE OUTSIDE CHINA? • Source: Shutterstock

Amid a global race to launch the first vaccine against the coronavirus and after Russia became the first nation to approve its candidate - albeit based on only small trials and limited data - many are now turning their attention to China, a front-runner with multiple vaccines now in final-stage development.

One Chinese health official recently disclosed that as early as 22 July, the country had issued emergency use authorizations (EUAs) to domestic COVID-19 vaccines still in late clinical trials. The...

More from Vaccines

More from Pink Sheet